Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7962469rdf:typepubmed:Citationlld:pubmed
pubmed-article:7962469lifeskim:mentionsumls-concept:C0031330lld:lifeskim
pubmed-article:7962469lifeskim:mentionsumls-concept:C0171346lld:lifeskim
pubmed-article:7962469lifeskim:mentionsumls-concept:C0171348lld:lifeskim
pubmed-article:7962469pubmed:dateCreated1994-12-21lld:pubmed
pubmed-article:7962469pubmed:abstractTextOrg 31710 and Org 31806 are new antiprogestagens. These compounds were tested for their binding affinity to various steroid receptors and for their bio-activity in various animal models and the results were compared with those of RU38486 and ZK 98299. Both Org compounds are strong antiprogestagens with little antiglucocortocoid activity and are devoid of other hormonal activities except for some weak androgenic and anti-androgenic activity. The two compounds are more potent than RU38486 and ZK 98299 with respect to their anti-progestational activity and are more selective. The Org compounds are effective in inhibiting the development of tumours in the 7,12-dimethylbenz(a)anthracene (DMBA) rat model. Org 31710 and Org 31806 may be applied for both the treatment of breast tumours and the improvement of fertility control.lld:pubmed
pubmed-article:7962469pubmed:languageenglld:pubmed
pubmed-article:7962469pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:citationSubsetIMlld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7962469pubmed:statusMEDLINElld:pubmed
pubmed-article:7962469pubmed:monthJunlld:pubmed
pubmed-article:7962469pubmed:issn0268-1161lld:pubmed
pubmed-article:7962469pubmed:authorpubmed-author:KloosterboerH...lld:pubmed
pubmed-article:7962469pubmed:authorpubmed-author:SchoonenW GWGlld:pubmed
pubmed-article:7962469pubmed:authorpubmed-author:DeckersG HGHlld:pubmed
pubmed-article:7962469pubmed:issnTypePrintlld:pubmed
pubmed-article:7962469pubmed:volume9 Suppl 1lld:pubmed
pubmed-article:7962469pubmed:ownerNLMlld:pubmed
pubmed-article:7962469pubmed:authorsCompleteYlld:pubmed
pubmed-article:7962469pubmed:pagination47-52lld:pubmed
pubmed-article:7962469pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:meshHeadingpubmed-meshheading:7962469-...lld:pubmed
pubmed-article:7962469pubmed:year1994lld:pubmed
pubmed-article:7962469pubmed:articleTitlePharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.lld:pubmed
pubmed-article:7962469pubmed:affiliationOrganon Scientific Development Group, Department of Endocrinology, Oss, The Netherlands.lld:pubmed
pubmed-article:7962469pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7962469pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7962469lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7962469lld:pubmed